Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 11 04:00PM ET
19.92
Dollar change
-0.29
Percentage change
-1.43
%
IndexRUT P/E14.73 EPS (ttm)1.35 Insider Own7.44% Shs Outstand57.71M Perf Week-2.83%
Market Cap1.15B Forward P/E6.58 EPS next Y3.03 Insider Trans0.00% Shs Float53.41M Perf Month26.32%
Income78.30M PEG2.26 EPS next Q0.44 Inst Own90.76% Short Float2.28% Perf Quarter26.56%
Sales1.12B P/S1.02 EPS this Y14.49% Inst Trans-1.16% Short Ratio3.14 Perf Half Y55.75%
Book/sh-12.79 P/B- EPS next Y7.93% ROA6.26% Short Interest1.22M Perf Year12.93%
Cash/sh4.75 P/C4.19 EPS next 5Y6.51% ROE- 52W Range9.93 - 21.48 Perf YTD5.23%
Dividend Est.0.60 (3.00%) P/FCF57.76 EPS past 5Y- ROI9.13% 52W High-7.26% Beta1.20
Dividend TTM0.60 (3.01%) Quick Ratio1.58 Sales past 5Y0.32% Gross Margin64.94% 52W Low100.71% ATR (14)1.08
Dividend Ex-DateDec 06, 2024 Current Ratio2.03 EPS Y/Y TTM10.44% Oper. Margin25.07% RSI (14)66.16 Volatility4.34% 6.08%
Employees2200 Debt/Eq- Sales Y/Y TTM0.21% Profit Margin6.97% Recom2.75 Target Price20.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q139.46% Payout44.78% Rel Volume0.84 Prev Close20.21
Sales Surprise3.30% EPS Surprise24.31% Sales Q/Q1.49% EarningsNov 26 BMO Avg Volume388.21K Price19.92
SMA2014.05% SMA5028.98% SMA20043.46% Trades Volume324,764 Change-1.43%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Upgrade Morgan Stanley Underweight → Equal-Weight $13 → $20
Nov-27-24Upgrade BTIG Research Neutral → Buy $26
Oct-20-23Initiated Wolfe Research Peer Perform
Jan-06-23Downgrade Morgan Stanley Equal-Weight → Underweight $28
Sep-08-22Initiated BTIG Research Neutral
Aug-01-22Initiated Morgan Stanley Equal-Weight $33
Jun-21-22Initiated BofA Securities Underperform $25
Dec-09-24 08:50AM
Dec-06-24 06:00AM
Nov-27-24 06:40AM
02:02AM
12:26AM
01:15PM Loading…
Nov-26-24 01:15PM
07:40AM
06:40AM
06:30AM
06:00AM
Nov-18-24 10:00AM
Nov-12-24 05:31PM
05:00PM
Nov-07-24 06:30AM
Sep-03-24 07:55AM
06:30AM Loading…
06:30AM
Aug-22-24 05:00PM
Aug-12-24 09:35AM
09:30AM
Aug-10-24 08:18AM
Aug-09-24 10:52AM
07:40AM
06:30AM
06:00AM
Aug-02-24 10:00AM
Jul-31-24 09:47AM
Jul-29-24 08:05AM
Jul-24-24 04:21AM
Jul-22-24 07:42AM
Jul-18-24 05:00PM
07:47AM Loading…
Jun-25-24 07:47AM
Jun-24-24 06:30AM
Jun-20-24 07:30AM
May-21-24 04:30PM
May-13-24 11:52AM
May-10-24 02:12PM
May-09-24 10:54AM
06:30AM
06:00AM
May-01-24 05:00PM
Apr-23-24 05:00PM
Mar-06-24 06:00AM
Feb-10-24 08:55AM
Feb-09-24 10:07PM
11:43AM
07:45AM
07:07AM
06:30AM
06:00AM
Feb-07-24 05:00PM
Jan-24-24 05:00PM
Jan-21-24 08:33AM
Jan-09-24 06:00AM
Dec-14-23 05:00PM
Dec-01-23 06:00AM
05:13AM
Nov-29-23 05:00PM
Nov-22-23 09:34AM
Nov-21-23 07:23AM
07:15AM
07:13AM
05:30AM
05:00AM
Nov-14-23 10:00AM
Oct-31-23 06:50AM
Oct-25-23 05:00PM
Sep-28-23 08:10PM
Sep-06-23 05:00PM
Aug-11-23 06:08AM
Aug-08-23 10:19PM
06:30AM
06:00AM
Jul-11-23 05:00PM
Jun-30-23 06:15AM
Jun-21-23 08:00PM
May-20-23 08:26AM
May-15-23 05:38PM
05:00PM
09:30AM
09:30AM
May-13-23 08:16AM
12:05AM
May-12-23 06:30AM
06:15AM
06:00AM
May-01-23 01:08PM
Apr-26-23 08:00PM
Apr-22-23 07:20AM
Apr-21-23 06:15PM
Apr-20-23 05:00PM
Mar-26-23 08:45AM
Mar-22-23 06:46AM
Mar-10-23 10:32AM
Feb-24-23 10:00AM
05:50AM
Feb-22-23 05:00PM
Feb-16-23 07:28AM
Feb-15-23 04:53PM
05:32AM
Feb-14-23 06:54PM
Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Melcher David FDirectorFeb 12 '24Buy16.252,00032,50045,080Feb 12 07:08 PM